Dengue virus serotype 1

DB22664ApprovedVaccines

Dengue virus serotype 1 is one component of a live, attenuated, tetravalent dengue virus vaccine. Dengue virus serotype 1 is a serotype of Orthoflavivirus denguei known to cause dengue fever.

Mechanism: The primary mechanism of action of Qdenga is to replicate locally and elicit humoral and cellular immune responses against the four dengue virus serotypes.
Curator reviewed · 1 reference
Primary indication: Dengue virus serotype 1 is a component of Qdenga, which is indicated for the prevention of dengue disease in patients ≥4 years of age.Curator reviewed · 1 structured indication
Also known as: Dengue virus serotype 1 (live, attenuated) · Dengue virus type 1

Resolves to

Compound

UNII7FN6A2S3DZ

What you can answer from here — as of August 04, 2026

3Clinical trialsPhase, status and sponsor resolved per trial

1Structured indicationCondition, population, route and combination as fields, not prose

5ContraindicationsEach with its own population and attribute set

3+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Dengue virus serotype 1, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account